EPO and diabetes mellitus: There were no differences among comorbidities including diabetes mellitus, hypertension, stroke, and peripheral arteriography between groups C and E. There were also no differences in the major medical treatments, including antiaggregants, antihypertensive drugs, β-blockers, statins, and erythropoietin between groups C and E.